Table of Contents
Financial Highlights
Shareholder Letter
Analysis
Board of Directors
Financials
Dr. Beckman's Birthday
 

Page One | Page Two | Page Three | Page Four | Page Five | Page Six |
Page Seven | Page Eight | Page Nine | Page Ten | Page Eleven | Page Twelve

  FINANCIALS  
Back | Next 

 
Selected Financial Information
 

Years Ended December 31,

1999

1998

1997

1996

1995

Summary of Operations

Sales

$1,808.7
$1,718.2
$1,198.0
$1,028.0
$930.1
Operating income before special charges(1)
$ 216.3
$ 133.9
$ 104.4
$ 122.5
$110.8

Earnings before special and

non-recurring charges, after taxes

$ 105.9

$ 44.7

$ 54.0

$ 74.7

$ 66.1

Special charges:
In-process research and development
(282.0)
Restructure credit (charge), net of tax
0.1
(11.2)
(36.4)
(17.2)

Net earnings (loss)

$ 106.0
$ 33.5
$ (264.4)
$ 74.7
$ 48.9

Diluted earnings per

share before special charges

$ 3.57
$ 1.52
$ 1.88
$ 2.58
$ 2.29

Diluted earnings (loss) per share

$ 3.57
$ 1.14
$ (9.58)
$ 2.58
$ 1.70

Dividends paid per share of common stock

$ 0.64
$ 0.61
$ 0.60
$ 0.52
$ 0.44

Shares outstanding (millions)

29.0
28.4
27.6
28.0
28.3

Weighted average common shares and dilutive

common share equivalents (millions)(2)

29.7
29.3
27.6
28.9
28.8

Other Information

Total assets

$2,110.8
$2,133.3
$2,331.0
$ 960.1
$907.8

Long-term debt, less current maturities

$ 980.7
$ 982.2
$1,181.3
$ 176.6
$162.7

Working capital

$ 390.5
$ 237.3
$ 81.8
$ 300.1
$282.1

EBIT before special charges(1)(3)

$ 228.3
$ 153.5
$ 118.9
$ 129.6
$113.5

Depreciation and amortization expense

$ 143.7
$ 152.4
$ 109.1
$ 87.8
$ 79.1

EBITDA before special charges(1)(3)

$ 372.0
$ 305.9
$ 228.0
$ 217.4
$192.6

EBITDA(3)

$ 372.2
$ 286.8
$ (113.4)
$ 217.4
$164.9

Debt to EBITDA before special charges(1)(3)

2.8
3.7
5.5
0.9
0.9

Capital expenditures

$ 134.9
$ 165.2
$ 100.9
$ 110.5
$103.2

Number of employees at December 31,

9,520
10,064
11,171
6,079
5,702

(1) Excludes pre-tax special charges. Special charges include: 1) restructure (credits) charges of $(0.2), $19.1, $59.4, and $27.7 in 1999, 1998, 1997, and 1995, respectively, and 2) a one time write-off of $282.0 of acquired in-process research and development relating to the Coulter acquisition in 1997. Including these special charges, the Company reported operating income (loss) of $216.5, $114.8, ($237.0), and $83.1 in 1999, 1998, 1997, and 1995 respectively. The Company did not incur any special charges in 1996.
(2) Under Generally Accepted Accounting Principles (“GAAP”), as the Company was in a net loss position in 1997, 1.0 million common share equivalents were not used to compute diluted loss per share, as the effect was antidilutive.
(3) EBIT is earnings before interest expense and taxes; EBITDA is EBIT before depreciation and amortization expense.

 

Back | Top | Next

 

 Annual Report 1999 
© 1999 Beckman Coulter, Inc. - www.beckmancoulter.com